Bulsa M

ORCID: 0000-0003-2748-6541 · 1 paper in corpus

2021

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?

Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11040626

The aim of our research was to determine the use of CA125 and HE4 as prognostic factors in patients with different clinical staging of endometrial cancer. Sixty-two patients with advanced endometrial cancer and 287 patients with early stage…